Satralizumab 60422-0367
Product NDC
60422-0367- Manufacturer
- Chugai Pharmaceutical Co., Ltd.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- August 14, 2020
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Satralizumab | 120 mg/mL |
Packaging Options(1)
1 SYRINGE, PLASTIC in 1 CARTON (60422-367-01) / 1 mL in 1 SYRINGE, PLASTIC